Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines.
Gabriela Beatriz GomezMariana SiapkaFrancesca ConradieNorbert NdjekaAnna Marie Celina GarfinNino LomtadzeZaza AvalianiNana KiriaShelly MalhotraSarah Cook-ScaliseSandeep JunejaDaniel EverittMelvin SpigelmanAnna VassallPublished in: BMJ open (2021)
Our results estimate that BPaL can be a cost-saving addition to the local TB programmes in varied programmatic settings.